You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
16 September 2026 - Healthcare technology company Medtronic (NYSE: MDT) announced on Wednesday that it has received US Food and Drug Administration clearance for its LigaSure RAS Maryland jaw device for use with the Hugo robotic-assisted surgery syst...
16 September 2026 - Jubilant Therapeutics Inc, a US-based clinical-stage biopharmaceutical company advancing precision therapies for hematological malignancies, announced on Tuesday the presentation of the first clinical data from its ongoing Phase 1...
16 September 2026 - Skyhawk Therapeutics Inc, a clinical-stage biotechnology company developing novel small molecule therapies designed to modulate RNA targets, announced on Tuesday the final 15-month results from its Phase 1/2 clinical trial evaluat...
16 September 2026 - Colombian biotechnology company VaxThera S.A.S. and US-based Codagenix Inc, a clinical-stage biotechnology company focused on synthetic biology-based vaccines, announced on Tuesday an agreement on terms for VaxThera to exclusively...
15 September 2026 - Biopharmaceutical company GSK plc (LON:GSK) (NYSE:GSK) announced on Tuesday that it has agreed to acquire a potential best-in-class trispecific T cell-engager (TCE) from privately held biotechnology company Chimagen Biosciences.Th...
15 September 2026 - PSMA Connect, a Healthcare Group Purchasing Organisation (GPO), and HealthIQ Solutions, a provider of remote patient care management and clinical technology, said on Monday that they have formed a new strategic provider alliance.T...
14 September 2026 - Chinese biopharmaceutical company Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG: 6990) on Monday announced that it has published phase III results for its HER2-targeted antibody–drug conjugate trastuzumab botidotin ...